Table 5.
Assessment of biochemical parameters as risk factors of development of diabetes and CVD
| Parameters | Control | Case | OR(95% CI) | Chi2 | P-Value | |
| FBS(mmol/l) | Low | 83(58.9) | 86(52.4) | 0.9(0.6–1.5) | 0.08 | 0.7780 |
| *Normal | 55(39.0) | 61(37.2) | 1 | |||
| High | 3(2.1) | 17(10.4) | 5.1(1.3–28.4) | 7.33 | 0.0068 | |
| TC(mmol/l) | Low | 45(31.9) | 15(9.2) | 0.2(0.1–0.4) | 23.68 | 0.0000 |
| *Normal | 95(76.4) | 143(87.2) | 1 | |||
| High | 1(0.7) | 6(3.7) | 4.0(0.5–185.2) | 1.87 | 0.1710 | |
| TRIG(mmol/l) | Low | 0(0) | 1(0.6) | ------ | 0.87 | 0.3502 |
| *Normal | 113(80.1) | 129(78.7) | 1 | |||
| High | 28(19.9) | 34(20.7) | 1.1(0.6–1.9) | 0.05 | 0.8290 | |
| HDLC(mmol/l) | Low | 84(59.6) | 71(43.3) | 0.4(0.3–0.8) | 10.44 | 0.0012 |
| *Normal | 48(34.0) | 88(53.7) | 1 | |||
| High | 9(6.4) | 5(3.1) | 0.3(0.1–1.1) | 4.53 | 0.0333 | |
| LDLC(mmol/l) | Low | 138(97.9) | 143(87.2) | 0.1(0.0–0.6) | 8.98 | 0.0027 |
| *Normal | 2(1.4) | 15(9.2) | 1 | |||
| High | 1(0.7) | 6(3.7) | 0.8(0.0–55.0) | 0.03 | 0.8652 | |
| CD4(cells/ul) | *Low | 52(36.9) | 18(11.0) | 1 | ||
| Normal | 89(63.1) | 146(89.0) | 4.7(2.5–9.1) | 28.77 | 0.0000 |
FBS: Fasting blood glucose; TC: Total cholesterol; TRIG: Triglycerides; HDLC: High density lipoprotein cholesterol; LDLC: Low density lipoprotein cholesterol; CD4: Cluster of differentiation 4. OR; Odd Ratio (crude), CI, Confidence Interval.
Table 5 presents the analysis for co morbidity for type II diabetes and CVD. Total cholesterol was higher in the cases than the control and the difference was statistically significant (P=0.0068). Also, LDL in the cases were nonsignificantly higher than in the controls (P=0.8652)